Skip to main content
NIH funding notice PAR-23-281

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Closed on November 5, 2024.

Posted
August 18, 2023
Close date
November 5, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,327,293 in first-year total cost, median $654,197.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 CTH-D (55)]4
  2. Special Emphasis Panel[ZRG1 CTH-C (55)]3
  3. Special Emphasis Panel[ZRG1 CTH-L (55)]1
  4. Special Emphasis Panel[ZRG1 MCTB-D (90)]1

Most frequent institutions

  1. J. DAVID GLADSTONE INSTITUTES1
  2. MASSACHUSETTS GENERAL HOSPITAL1
  3. NORTHWESTERN UNIVERSITY1
  4. TUFTS UNIVERSITY BOSTON1
  5. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
Competing awards under PAR-23-281 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Determine genotypic, phenotypic and evolutionary trajectories of treatment resistance to radiotherapy.1R01CA299011-01GOPAL, PRIYANKANORTHWESTERN UNIVERSITY, IL$2,105,127ZRG1
2025Modelling the dynamics of spontaneous clonal hematopoiesis in pet dogs during cancer therapy1R01CA294792-01A1BICK, ALEXANDERKARLSSON, ELINORLONDON, CHERYL ATUFTS UNIVERSITY BOSTON, MA$742,391ZRG1
2025A spatial profiling-based immune hub perturbation platform to improve immunotherapy in colon cancer1R37CA295736-01A1PELKA, KARINJ. DAVID GLADSTONE INSTITUTES, CA$710,361ZRG1
2025Pancreatic cancer patient-derived xenograft tumors for translational studies in precision cancer medicine1R01CA293063-01A1LISS, ANDREWWEISSLEDER, MD, PHD, RALPHMASSACHUSETTS GENERAL HOSPITAL, MA$654,197ZRG1
2025Porcine Platforms For Technology Development In Pancreatic Cancer1R01CA295693-01HOLLINGSWORTH, MICHAEL A.MAMMEN, JOSHUA M.V.UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$635,749ZRG1
2025Modeling lung squamous cell carcinoma premalignancy and prevention1R01CA298925-01TENNIS, MEREDITH AUNIVERSITY OF COLORADO DENVER, CO$602,315ZRG1
2025Single-cell congruence evaluation and selection of cancer models towards precision medicine1R01CA285337-01A1LEE, ADRIAN VTSENG, GEORGE C.UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$585,931ZRG1
2024A network approach to interrogate cellular plasticity and drug resistance in cancer1R01CA285426-01A1AKHURST, ROSEMARY JBALMAIN, ALLANUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$671,594ZRG1
2024Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma1R37CA285434-01A1BINDER, ZEV ARIUNIVERSITY OF PENNSYLVANIA, PA$619,628ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.